v3.25.1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
ATM Program
Ordinary Shares
Ordinary Shares
ATM Program
Additional paid-in capital
Additional paid-in capital
ATM Program
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023     98,774,827          
Beginning balance at Dec. 31, 2023 $ 236,244   $ 273   $ 987,423   $ 1,493 $ (752,945)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of ordinary shares under ATM program, net of issuance costs (in shares)       1,250,000        
Issuance of ordinary shares under ATM program, net of issuance costs   $ 9,655   $ 3   $ 9,652    
Stock option exercises (in shares)     176,460          
Stock option exercises 955       955      
Share-based compensation expense 8,154       8,154      
Vesting of ordinary shares (in shares)     480,926          
Vesting of ordinary shares 0   $ 1   (1)      
Shares withheld to pay employee withholding tax on share-based compensation (in shares)     (200,220)          
Shares withheld to pay employee withholding tax on share-based compensation (1,929)       (1,929)      
Foreign currency translation adjustments (25)           (25)  
Unrealized gain on available for sale securities, net of tax 155           155  
Net loss (38,046)             (38,046)
Ending balance (in shares) at Mar. 31, 2024     100,481,993          
Ending balance at Mar. 31, 2024 $ 215,163   $ 277   1,004,254   1,623 (790,991)
Beginning balance (in shares) at Dec. 31, 2024 132,631,587   132,631,587          
Beginning balance at Dec. 31, 2024 $ 401,545   $ 359   1,385,675   4,213 (988,702)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of ordinary shares under ATM program, net of issuance costs (in shares)       372,538        
Issuance of ordinary shares under ATM program, net of issuance costs   $ 6,109   $ 1   $ 6,108    
Stock option exercises (in shares) 280,716   280,716          
Stock option exercises $ 1,880   $ 1   1,879      
Share-based compensation expense 7,883       7,883      
Vesting of ordinary shares (in shares)     440,909          
Vesting of ordinary shares 0   $ 1   (1)      
Shares withheld to pay employee withholding tax on share-based compensation (in shares)     (171,152)          
Shares withheld to pay employee withholding tax on share-based compensation (2,897)       (2,897)      
Foreign currency translation adjustments 643           643  
Unrealized gain on available for sale securities, net of tax 6           6  
Reclassification adjustment for realized net gain on available for sale marketable securities included in net loss, net of tax 2,787           2,787  
Net loss $ (26,135)             (26,135)
Ending balance (in shares) at Mar. 31, 2025 133,554,598   133,554,598          
Ending balance at Mar. 31, 2025 $ 386,247   $ 362   $ 1,398,647   $ 2,075 $ (1,014,837)